IMC Chicago
VRTX icon

IMC Chicago’s Vertex Pharmaceuticals VRTX Stock Holding History

IMC Chicago’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.6M Sell
79,800
-44,000
-36% -$20.5M 0.01% 620
2025
Q4 		$56.1M Buy
123,800
+17,900
+17% +$7.72M 0.02% 463
2025
Q3 		$41.5M Buy
105,900
+69,000
+187% +$28.8M 0.02% 515
2025
Q2 		$16.4M Buy
36,900
+4,400
+14% +$2.03M 0.01% 784
2025
Q1 		$15.8M Sell
32,500
-57,100
-64% -$26.6M 0.01% 680
2024
Q4 		$36.1M Buy
89,600
+60,100
+204% +$27.9M 0.02% 425
2024
Q3 		$13.7M Sell
29,500
-18,700
-39% -$8.98M 0.01% 702
2024
Q2 		$22.6M Buy
48,200
+11,200
+30% +$4.86M 0.01% 493
2024
Q1 		$15.5M Sell
37,000
-7,800
-17% -$3.3M 0.01% 545
2023
Q4 		$18.2M Sell
44,800
-3,100
-6% -$1.15M 0.01% 484
2023
Q3 		$16.7M Buy
47,900
+2,200
+5% +$769K 0.01% 423
2023
Q2 		$16.1M Buy
45,700
+2,700
+6% +$910K 0.01% 410
2023
Q1 		$13.5M Buy
43,000
+800
+2% +$240K 0.02% 423
2022
Q4 		$12.2M Buy
42,200
+12,800
+44% +$3.9M 0.02% 421
2022
Q3 		$8.51M Buy
+29,400
New +$8.46M 0.01% 466
2022
Q2 		– Sell
-18,200
Closed -$4.75M – 1184
2022
Q1 		$4.75M Buy
+18,200
New +$4.32M ﹤0.01% 573
2021
Q4 		– Sell
-23,800
Closed -$4.32M – 1334
2021
Q3 		$4.32M Buy
+23,800
New +$4.65M ﹤0.01% 650
2021
Q1 		– Sell
-10,600
Closed -$2.5M – 1193
2020
Q4 		$2.5M Buy
+10,600
New +$2.43M ﹤0.01% 687
2019
Q1 		– Sell
-4,400
Closed -$729K – 907
2018
Q4 		$729K Buy
+4,400
New +$762K ﹤0.01% 516

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

IMC Chicago's VRTX Position: Q1 2026 in Review

IMC Chicago opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 4,533 shares worth $2.02M. The stake represents ﹤0.01% of the portfolio and ranks #2555 among its holdings.

1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • IMC Chicago held 4,533 shares of Vertex Pharmaceuticals worth $2.02M as of Q1 2026.
  • Vertex Pharmaceuticals was a new IMC Chicago position in Q1 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #2555 holding.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.